Creative Medical Tech Q1 2025: Warrants and Patents
Ticker: CELZ · Form: 10-Q · Filed: May 9, 2025 · CIK: 1187953
Sentiment: neutral
Topics: warrants, revenue, patents, licensing
TL;DR
Creative Medical Tech Q1 2025: $25M in warrants, minimal revenue. Patents and licensing are key.
AI Summary
Creative Medical Technology Holdings, Inc. filed a 10-Q for the period ending March 31, 2025. The company reported $0.001 in revenue and had $25,000,000 in warrants outstanding. The filing also mentions licensing agreements and patents as key assets.
Why It Matters
This filing provides insight into the financial health and potential future dilution for Creative Medical Technology Holdings, Inc. due to outstanding warrants.
Risk Assessment
Risk Level: medium — The significant amount of outstanding warrants ($25,000,000) presents a risk of future dilution for shareholders.
Key Numbers
- $25.0B — Warrants (Represents potential future dilution)
- $0.001 — Revenue (Minimal revenue reported for the period)
Key Players & Entities
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (company) — Filer
- 25000000 (dollar_amount) — Warrants outstanding
- 0.001 (dollar_amount) — Revenue
- 20250331 (date) — Reporting period end date
FAQ
What is the total value of outstanding warrants as of March 31, 2025?
The total value of outstanding warrants is $25,000,000.
What was the reported revenue for the quarter ending March 31, 2025?
The reported revenue for the quarter ending March 31, 2025, was $0.001.
What are the company's primary business activities mentioned in the filing?
The company's business activities include licensing agreements and patents, specifically related to IND patents and ImmCelz.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the SIC code for Creative Medical Technology Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 2836, for Biological Products (No Diagnostic Substances).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ).